
AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
The Largest Healthcare Companies by Market Cap in April 2025
Eli Lilly, UnitedHealth Group, and Johnson & Johnson command the healthcare sector.
2 Top Dividend Stocks That Could Set You Up for Life
3 Dividend Stocks to Buy and Hold for the Next Decade
3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About
8 Best Index Funds to Buy in April 2025
Here are the eight best index funds to add to your portfolio for steady, low-cost growth.
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
3 Relatively Safe Stocks to Buy Right Now
2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income
Valuation
Earnings Transcripts
AbbVie (ABBV) Q4 2024 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2024.
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2024.
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2024.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.